Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
8 pending office actions • 7 art units • 7 examiners • 0 of 8 (0%) have an AI response strategy ready • 6 patents granted in the last 365 days
Reckitt Benckiser Health Limited has 8 pending office actions in Biotechnology & Pharmaceuticals. The matters involve 7 distinct examiners and 7 distinct art units, indicating broad distribution across the examining organization. The portfolio therefore calls for coordination across several prosecution channels rather than reliance on a single examiner strategy.
ASDJODI, MOHAMMADREZA is the busiest examiner, with 2 pending matters. That assignment is the only examiner concentration identified in the data, making it a practical point for reviewing recurring claim language, amendment choices, and response timing.
For the other matters, counsel should preserve a unified position on core technical disclosures while adapting arguments to the specific art-unit context. The spread of assignments also makes internal tracking important, particularly where related inventions may receive different examination approaches.
Based on the USPTO statutory response window for each pending office action. 7 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 7 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 5 (62%) |
| Double-patenting + other | 1 (12%) |
| Multi-statute (no §101) | 2 (25%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ASDJODI, MOHAMMADREZA | 2 | 59.1% | +46.9% |
| MELENDEZ, ARMAND | 1 | 46.1% | +43.1% |
| ABBAS, ABDULRAHMAN MUSTAFA | 1 | 51.6% | +29.8% |
| BROWE, DAVID | 1 | 26.7% | +28.0% |
| LEE, ANDREW P | 1 | 48.5% | +22.8% |
| LEE, MICHELLE J | 1 | 39.8% | +60.2% |
| ZHANG SPIERING, DONGXIU | 1 | 41.2% | +65.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17916164 | PURE POLYURETHANE CONDOM HAVING ADHESIVE LAYER AND PREPARATION METHOD THEREFOR | LEE, MICHELLE J | 73d overdue |
| 18261290 | LUBRICANT | BROWE, DAVID | 31d overdue |
| 17785959 | Personal Lubricant Composition | ZHANG SPIERING, DONGXIU | 12d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17916164 | PURE POLYURETHANE CONDOM HAVING ADHESIVE LAYER AND PREPARATION METHOD THEREFOR | LEE, MICHELLE J | 73d overdue |
| 18577534 | NOVEL USE OF POLYMER COMBINATION | ABBAS, ABDULRAHMAN MUSTAFA | 66d overdue |
| 18261290 | LUBRICANT | BROWE, DAVID | 31d overdue |
| 18573628 | LAUNDRY SANITIZING COMPOSITION | ASDJODI, MOHAMMADREZA | 8d overdue |
| 17785959 | Personal Lubricant Composition | ZHANG SPIERING, DONGXIU | 12d |
| 18716337 | LAUNDRY SANITIZING AND SOFTENING COMPOSITION | ASDJODI, MOHAMMADREZA | 13d |
| 18851411 | LAMINATE HAVING IMPROVED TENSILE PROPERTIES | MELENDEZ, ARMAND | 49d |
| 17999073 | IBUPROFEN CONTAINING SOFT GELATINE CAPSULE | LEE, ANDREW P | — |
| Art Unit | Apps |
|---|---|
| 1767 | 2 |
| 1759 | 1 |
| 1612 | 1 |
| 1617 | 1 |
| 1691 | 1 |
| 3786 | 1 |
| 1616 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18851411 | LAMINATE HAVING IMPROVED TENSILE PROPERTIES | MELENDEZ, ARMAND | 1759 | §103 | Non-Final OA | 49d | Pending | Sep 26, 2024 |
| 18716337 | LAUNDRY SANITIZING AND SOFTENING COMPOSITION | ASDJODI, MOHAMMADREZA | 1767 | §103 | Final Rejection | 13d | Pending | Jun 04, 2024 |
| 18577534 | NOVEL USE OF POLYMER COMBINATION | ABBAS, ABDULRAHMAN MUSTAFA | 1612 | §103DP | Final Rejection | 66d overdue | Pending | Jan 08, 2024 |
| 18573628 | LAUNDRY SANITIZING COMPOSITION | ASDJODI, MOHAMMADREZA | 1767 | §103 | Final Rejection | 8d overdue | Pending | Dec 22, 2023 |
| 18261290 | LUBRICANT | BROWE, DAVID | 1617 | §103 | Non-Final OA | 31d overdue | Pending | Jul 13, 2023 |
| 17999073 | IBUPROFEN CONTAINING SOFT GELATINE CAPSULE | LEE, ANDREW P | 1691 | §103 | Final Rejection | — | Pending | Nov 17, 2022 |
| 17916164 | PURE POLYURETHANE CONDOM HAVING ADHESIVE LAYER AND PREPARATION METHOD THEREFOR | LEE, MICHELLE J | 3786 | §103§112 | Final Rejection | 73d overdue | Pending | Sep 30, 2022 |
| 17785959 | Personal Lubricant Composition | ZHANG SPIERING, DONGXIU | 1616 | §103§112 | Non-Final OA | 12d | Pending | Jun 16, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialReckitt Benckiser Health Limited has 8 pending office actions as of October 2026, spread across 7 art units and 7 examiners.
Mohammadreza Asdjodi has the most, with 2 of Reckitt Benckiser Health Limited's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
